Prior to COVID-19, telehealth was often used as an alternative to in-person care, to maintain continuity of care, or in combination. Given the current climate of COVID-19 and the rapidly changing landscape of treatment implementation, telehealth has become the go-to method of delivery for mental health services. Telehealth has become useful for providing cognitive behavioral therapy to young children to adults, and in various formats (i.e., individual, group, intensive). This quick demand for telehealth need has also placed pressure on improving regulations and laws related to telehealth within and across state lines. This webinar will describe examples of how telehealth can be used to provide evidence-based care in clinical and research settings for a variety of disorders and presentations. Examples of cases using telehealth with evidence-based treatments will be presented. Ethical considerations when using telehealth such as consenting, privacy, HIPAA compliance, interjurisdictional practice, and appropriateness of clients for telehealth services, particularly the changes that may have occurred regarding COVID-19.
1. Present current research base and clinical practice of telehealth for evidence-based treatments.
2. Describe adaptations to treatment when conducting evidence-based care via telehealth.
3. Discuss ethical considerations and privacy concerns when implementing evidence-based care via telehealth.
Rachel Busman, PsyD, is the senior director of the Anxiety Disorders Center and director of the Selective Mutism Service at the Child Mind Institute. She leads a team of clinicians providing evaluation and innovative treatment to children with selective mutism. Dr. Busman is President of the Selective Mutism Association, the nation’s largest network of professionals, families, and individuals with selective mutism.
Dr. Busman has extensive experience providing cognitive behavioral therapy (CBT) to children, teenagers and young adults struggling with anxiety disorders and school difficulties. She also has specific interest and expertise in the evaluation and treatment of obsessive-compulsive disorder, separation anxiety disorder, social anxiety disorder and specific phobias.
Dr. Busman has worked with children in both inpatient and outpatient settings at a major academic medical center, where she directed a multidisciplinary team. She has taught and supervised psychiatry residents and child psychiatry fellows, and lectured extensively on a variety of topics, including the evidence-based assessment and treatment of anxiety disorders in children and teens.
Dr. Busman works intensively with children who have selective mutism, and is dedicated to establishing trust and instilling a sense of hope in her patients as she helps them on their path to recovery.
Jami Furr, Ph.D. is a Clinical Assistant Professor and Senior Psychologist in the Mental Health Interventions and Technology (MINT) Program, and the Selective Mutism Program at the Center for Children and Families at Florida International University (FIU). She is the President of the Selective Mutism Association, a nonprofit organization promoting awareness and resources regarding selective mutism to professionals, educators, and families. Dr. Furr has extensive expertise in cognitive-behavioral treatments of childhood anxiety and disruptive behavior disorders, with a focus on preschool mental health and intensive group treatment programs for children with selective mutism – directing the first randomized clinical trial of the intensive group behavioral treatment for selective mutism in young children. She has supervised doctoral, masters, and undergraduate students and provided extensive trainings in anxiety disorders in youth to these students, school psychologists, other educators, and the surrounding communities. Dr. Furr received her M.A. and Ph.D. in Clinical Psychology from Temple University. Dr. Furr completed her clinical psychology internship at the NYU-Bellevue Clinical Psychology Internship Program and the NYU Child Study Center, after which she completed an NIH-funded Postdoctoral Fellowship in Child Psychiatry at the NYU Child Study Center. Prior to FIU, she served as the Clinical Director of the Child Fear and Anxiety Program at Boston University’s Center for Anxiety and Related Disorders.